Prevalence of Myopic Maculopathy Among Adults in a Russian Population
IMPORTANCE: Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available. OBJECTIVE: To assess the prevalence of myopic maculopathy and its associations with ocular and systemic...
Uloženo v:
| Vydáno v: | JAMA Network Open Ročník 3; číslo 3; s. e200567 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
American Medical Association
06.03.2020
|
| Témata: | |
| ISSN: | 2574-3805, 2574-3805 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | IMPORTANCE: Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available. OBJECTIVE: To assess the prevalence of myopic maculopathy and its associations with ocular and systemic parameters in a population in Russia. DESIGN, SETTING, AND PARTICIPANTS: The Ural Eye and Medical Study, a population-based case-control study, was conducted in rural and urban areas in Bashkortostan, Russia, from October 26, 2015, to July 4, 2017. Data analysis was performed from September 13 to September 15, 2019. The Ural Eye and Medical Study included 5899 of 7328 eligible individuals (80.5%) aged 40 years or older. EXPOSURES: A detailed ocular and systemic examination included fundus photography and optic coherence tomography for the assessment of myopic maculopathy. MAIN OUTCOMES AND MEASURES: Prevalence of myopic maculopathy. RESULTS: The present investigation included 5794 of the 5899 eligible individuals (98.2%; 3277 [56.6%] women; mean [SD] age, 58.9 [10.7] years) with available information about myopic maculopathy. Mean (SD) axial length was 23.3 (1.1) mm (range, 19.78-32.87 mm). Prevalence of any myopic maculopathy was 1.3% (95% CI, 1.0%-1.6%); myopic maculopathy stage 2, 0.8% (95% CI, 0.6%-10.0%); stage 3, 0.2% (95% CI, 0.1%-0.4%); and stage 4, 0.2% (95% CI, 0.1%-0.4%). The prevalence of moderate to severe vision impairment and blindness was 29.8% (14 of 47 participants; 95% CI, 16.2%-43.3%) in stage 2 myopic maculopathy, 57.1% (8 of 14 participants; 95% CI, 27.5%-86.8%) in stage 3, and 100% (13 of 13 participants; 95% CI, 100%-100%) in stage 4. In multivariable analysis, a higher myopic maculopathy prevalence was associated with longer axial length (odds ratio [OR], 4.54; 95% CI, 3.48-5.92; P < .001), older age (OR, 1.04; 95% CI, 1.01-1.07; P = .03), and thinner peripapillary retinal nerve fiber layer thickness (OR, 0.96; 95% CI, 0.95-0.98; P < .001). After exclusion of glaucomatous eyes, the association between myopic maculopathy prevalence and thinner retinal nerve fiber layer remained significant (OR, 0.96; 95% CI, 0.95-0.98; P < .001). Myopic maculopathy prevalence was not significantly associated with sex; region of habitation; level of education; ethnicity; prevalence of arterial hypertension, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and inflammatory liver disease; hearing loss; depression score; or anxiety score. CONCLUSIONS AND RELEVANCE: In this ethnically mixed population from Russia, myopic maculopathy prevalence was mainly associated with elongated axial length and thinner peripapillary retinal nerve fiber layer, but was not associated with any major internal medical disease, level of education, ethnicity, or sex. Higher myopic maculopathy stage was associated with vision impairment and blindness. In addition to a known association between high axial myopia and glaucoma, myopic maculopathy may be associated with nonglaucomatous optic neuropathy. |
|---|---|
| AbstractList | Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available.
To assess the prevalence of myopic maculopathy and its associations with ocular and systemic parameters in a population in Russia.
The Ural Eye and Medical Study, a population-based case-control study, was conducted in rural and urban areas in Bashkortostan, Russia, from October 26, 2015, to July 4, 2017. Data analysis was performed from September 13 to September 15, 2019. The Ural Eye and Medical Study included 5899 of 7328 eligible individuals (80.5%) aged 40 years or older.
A detailed ocular and systemic examination included fundus photography and optic coherence tomography for the assessment of myopic maculopathy.
Prevalence of myopic maculopathy.
The present investigation included 5794 of the 5899 eligible individuals (98.2%; 3277 [56.6%] women; mean [SD] age, 58.9 [10.7] years) with available information about myopic maculopathy. Mean (SD) axial length was 23.3 (1.1) mm (range, 19.78-32.87 mm). Prevalence of any myopic maculopathy was 1.3% (95% CI, 1.0%-1.6%); myopic maculopathy stage 2, 0.8% (95% CI, 0.6%-10.0%); stage 3, 0.2% (95% CI, 0.1%-0.4%); and stage 4, 0.2% (95% CI, 0.1%-0.4%). The prevalence of moderate to severe vision impairment and blindness was 29.8% (14 of 47 participants; 95% CI, 16.2%-43.3%) in stage 2 myopic maculopathy, 57.1% (8 of 14 participants; 95% CI, 27.5%-86.8%) in stage 3, and 100% (13 of 13 participants; 95% CI, 100%-100%) in stage 4. In multivariable analysis, a higher myopic maculopathy prevalence was associated with longer axial length (odds ratio [OR], 4.54; 95% CI, 3.48-5.92; P < .001), older age (OR, 1.04; 95% CI, 1.01-1.07; P = .03), and thinner peripapillary retinal nerve fiber layer thickness (OR, 0.96; 95% CI, 0.95-0.98; P < .001). After exclusion of glaucomatous eyes, the association between myopic maculopathy prevalence and thinner retinal nerve fiber layer remained significant (OR, 0.96; 95% CI, 0.95-0.98; P < .001). Myopic maculopathy prevalence was not significantly associated with sex; region of habitation; level of education; ethnicity; prevalence of arterial hypertension, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and inflammatory liver disease; hearing loss; depression score; or anxiety score.
In this ethnically mixed population from Russia, myopic maculopathy prevalence was mainly associated with elongated axial length and thinner peripapillary retinal nerve fiber layer, but was not associated with any major internal medical disease, level of education, ethnicity, or sex. Higher myopic maculopathy stage was associated with vision impairment and blindness. In addition to a known association between high axial myopia and glaucoma, myopic maculopathy may be associated with nonglaucomatous optic neuropathy. IMPORTANCE: Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available. OBJECTIVE: To assess the prevalence of myopic maculopathy and its associations with ocular and systemic parameters in a population in Russia. DESIGN, SETTING, AND PARTICIPANTS: The Ural Eye and Medical Study, a population-based case-control study, was conducted in rural and urban areas in Bashkortostan, Russia, from October 26, 2015, to July 4, 2017. Data analysis was performed from September 13 to September 15, 2019. The Ural Eye and Medical Study included 5899 of 7328 eligible individuals (80.5%) aged 40 years or older. EXPOSURES: A detailed ocular and systemic examination included fundus photography and optic coherence tomography for the assessment of myopic maculopathy. MAIN OUTCOMES AND MEASURES: Prevalence of myopic maculopathy. RESULTS: The present investigation included 5794 of the 5899 eligible individuals (98.2%; 3277 [56.6%] women; mean [SD] age, 58.9 [10.7] years) with available information about myopic maculopathy. Mean (SD) axial length was 23.3 (1.1) mm (range, 19.78-32.87 mm). Prevalence of any myopic maculopathy was 1.3% (95% CI, 1.0%-1.6%); myopic maculopathy stage 2, 0.8% (95% CI, 0.6%-10.0%); stage 3, 0.2% (95% CI, 0.1%-0.4%); and stage 4, 0.2% (95% CI, 0.1%-0.4%). The prevalence of moderate to severe vision impairment and blindness was 29.8% (14 of 47 participants; 95% CI, 16.2%-43.3%) in stage 2 myopic maculopathy, 57.1% (8 of 14 participants; 95% CI, 27.5%-86.8%) in stage 3, and 100% (13 of 13 participants; 95% CI, 100%-100%) in stage 4. In multivariable analysis, a higher myopic maculopathy prevalence was associated with longer axial length (odds ratio [OR], 4.54; 95% CI, 3.48-5.92; P < .001), older age (OR, 1.04; 95% CI, 1.01-1.07; P = .03), and thinner peripapillary retinal nerve fiber layer thickness (OR, 0.96; 95% CI, 0.95-0.98; P < .001). After exclusion of glaucomatous eyes, the association between myopic maculopathy prevalence and thinner retinal nerve fiber layer remained significant (OR, 0.96; 95% CI, 0.95-0.98; P < .001). Myopic maculopathy prevalence was not significantly associated with sex; region of habitation; level of education; ethnicity; prevalence of arterial hypertension, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and inflammatory liver disease; hearing loss; depression score; or anxiety score. CONCLUSIONS AND RELEVANCE: In this ethnically mixed population from Russia, myopic maculopathy prevalence was mainly associated with elongated axial length and thinner peripapillary retinal nerve fiber layer, but was not associated with any major internal medical disease, level of education, ethnicity, or sex. Higher myopic maculopathy stage was associated with vision impairment and blindness. In addition to a known association between high axial myopia and glaucoma, myopic maculopathy may be associated with nonglaucomatous optic neuropathy. This case-control study examines the prevalence of myopic maculopathy among individuals aged 40 years or older in rural and urban areas in Russia. Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available.ImportanceAlthough myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic maculopathy have been available.To assess the prevalence of myopic maculopathy and its associations with ocular and systemic parameters in a population in Russia.ObjectiveTo assess the prevalence of myopic maculopathy and its associations with ocular and systemic parameters in a population in Russia.The Ural Eye and Medical Study, a population-based case-control study, was conducted in rural and urban areas in Bashkortostan, Russia, from October 26, 2015, to July 4, 2017. Data analysis was performed from September 13 to September 15, 2019. The Ural Eye and Medical Study included 5899 of 7328 eligible individuals (80.5%) aged 40 years or older.Design, Setting, and ParticipantsThe Ural Eye and Medical Study, a population-based case-control study, was conducted in rural and urban areas in Bashkortostan, Russia, from October 26, 2015, to July 4, 2017. Data analysis was performed from September 13 to September 15, 2019. The Ural Eye and Medical Study included 5899 of 7328 eligible individuals (80.5%) aged 40 years or older.A detailed ocular and systemic examination included fundus photography and optic coherence tomography for the assessment of myopic maculopathy.ExposuresA detailed ocular and systemic examination included fundus photography and optic coherence tomography for the assessment of myopic maculopathy.Prevalence of myopic maculopathy.Main Outcomes and MeasuresPrevalence of myopic maculopathy.The present investigation included 5794 of the 5899 eligible individuals (98.2%; 3277 [56.6%] women; mean [SD] age, 58.9 [10.7] years) with available information about myopic maculopathy. Mean (SD) axial length was 23.3 (1.1) mm (range, 19.78-32.87 mm). Prevalence of any myopic maculopathy was 1.3% (95% CI, 1.0%-1.6%); myopic maculopathy stage 2, 0.8% (95% CI, 0.6%-10.0%); stage 3, 0.2% (95% CI, 0.1%-0.4%); and stage 4, 0.2% (95% CI, 0.1%-0.4%). The prevalence of moderate to severe vision impairment and blindness was 29.8% (14 of 47 participants; 95% CI, 16.2%-43.3%) in stage 2 myopic maculopathy, 57.1% (8 of 14 participants; 95% CI, 27.5%-86.8%) in stage 3, and 100% (13 of 13 participants; 95% CI, 100%-100%) in stage 4. In multivariable analysis, a higher myopic maculopathy prevalence was associated with longer axial length (odds ratio [OR], 4.54; 95% CI, 3.48-5.92; P < .001), older age (OR, 1.04; 95% CI, 1.01-1.07; P = .03), and thinner peripapillary retinal nerve fiber layer thickness (OR, 0.96; 95% CI, 0.95-0.98; P < .001). After exclusion of glaucomatous eyes, the association between myopic maculopathy prevalence and thinner retinal nerve fiber layer remained significant (OR, 0.96; 95% CI, 0.95-0.98; P < .001). Myopic maculopathy prevalence was not significantly associated with sex; region of habitation; level of education; ethnicity; prevalence of arterial hypertension, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and inflammatory liver disease; hearing loss; depression score; or anxiety score.ResultsThe present investigation included 5794 of the 5899 eligible individuals (98.2%; 3277 [56.6%] women; mean [SD] age, 58.9 [10.7] years) with available information about myopic maculopathy. Mean (SD) axial length was 23.3 (1.1) mm (range, 19.78-32.87 mm). Prevalence of any myopic maculopathy was 1.3% (95% CI, 1.0%-1.6%); myopic maculopathy stage 2, 0.8% (95% CI, 0.6%-10.0%); stage 3, 0.2% (95% CI, 0.1%-0.4%); and stage 4, 0.2% (95% CI, 0.1%-0.4%). The prevalence of moderate to severe vision impairment and blindness was 29.8% (14 of 47 participants; 95% CI, 16.2%-43.3%) in stage 2 myopic maculopathy, 57.1% (8 of 14 participants; 95% CI, 27.5%-86.8%) in stage 3, and 100% (13 of 13 participants; 95% CI, 100%-100%) in stage 4. In multivariable analysis, a higher myopic maculopathy prevalence was associated with longer axial length (odds ratio [OR], 4.54; 95% CI, 3.48-5.92; P < .001), older age (OR, 1.04; 95% CI, 1.01-1.07; P = .03), and thinner peripapillary retinal nerve fiber layer thickness (OR, 0.96; 95% CI, 0.95-0.98; P < .001). After exclusion of glaucomatous eyes, the association between myopic maculopathy prevalence and thinner retinal nerve fiber layer remained significant (OR, 0.96; 95% CI, 0.95-0.98; P < .001). Myopic maculopathy prevalence was not significantly associated with sex; region of habitation; level of education; ethnicity; prevalence of arterial hypertension, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and inflammatory liver disease; hearing loss; depression score; or anxiety score.In this ethnically mixed population from Russia, myopic maculopathy prevalence was mainly associated with elongated axial length and thinner peripapillary retinal nerve fiber layer, but was not associated with any major internal medical disease, level of education, ethnicity, or sex. Higher myopic maculopathy stage was associated with vision impairment and blindness. In addition to a known association between high axial myopia and glaucoma, myopic maculopathy may be associated with nonglaucomatous optic neuropathy.Conclusions and RelevanceIn this ethnically mixed population from Russia, myopic maculopathy prevalence was mainly associated with elongated axial length and thinner peripapillary retinal nerve fiber layer, but was not associated with any major internal medical disease, level of education, ethnicity, or sex. Higher myopic maculopathy stage was associated with vision impairment and blindness. In addition to a known association between high axial myopia and glaucoma, myopic maculopathy may be associated with nonglaucomatous optic neuropathy. |
| Author | Yakupova, Dilya F Zinatullin, Ainur A Bikbov, Mukharram M Uzianbaeva, Yulia V Jonas, Jost B Rakhimova, Ellina M Rusakova, Iulia A Panda-Jonas, Songhomitra Gilmanshin, Timur R Zainullin, Rinat M Safiullina, Kamila R Bolshakova, Natalia I Khalimov, Timur A Zaynetdinov, Artur F Bikbova, Guzel M Arslangareeva, Inga I Nuriev, Ildar F Kazakbaeva, Gyulli M |
| AuthorAffiliation | 1 Ufa Eye Research Institute, Ufa, Bashkortostan, Russia 2 Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany |
| AuthorAffiliation_xml | – name: 2 Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany – name: 1 Ufa Eye Research Institute, Ufa, Bashkortostan, Russia |
| Author_xml | – sequence: 1 givenname: Mukharram M surname: Bikbov fullname: Bikbov, Mukharram M – sequence: 2 givenname: Timur R surname: Gilmanshin fullname: Gilmanshin, Timur R – sequence: 3 givenname: Gyulli M surname: Kazakbaeva fullname: Kazakbaeva, Gyulli M – sequence: 4 givenname: Rinat M surname: Zainullin fullname: Zainullin, Rinat M – sequence: 5 givenname: Ellina M surname: Rakhimova fullname: Rakhimova, Ellina M – sequence: 6 givenname: Iulia A surname: Rusakova fullname: Rusakova, Iulia A – sequence: 7 givenname: Natalia I surname: Bolshakova fullname: Bolshakova, Natalia I – sequence: 8 givenname: Kamila R surname: Safiullina fullname: Safiullina, Kamila R – sequence: 9 givenname: Artur F surname: Zaynetdinov fullname: Zaynetdinov, Artur F – sequence: 10 givenname: Ainur A surname: Zinatullin fullname: Zinatullin, Ainur A – sequence: 11 givenname: Ildar F surname: Nuriev fullname: Nuriev, Ildar F – sequence: 12 givenname: Timur A surname: Khalimov fullname: Khalimov, Timur A – sequence: 13 givenname: Songhomitra surname: Panda-Jonas fullname: Panda-Jonas, Songhomitra – sequence: 14 givenname: Inga I surname: Arslangareeva fullname: Arslangareeva, Inga I – sequence: 15 givenname: Guzel M surname: Bikbova fullname: Bikbova, Guzel M – sequence: 16 givenname: Dilya F surname: Yakupova fullname: Yakupova, Dilya F – sequence: 17 givenname: Yulia V surname: Uzianbaeva fullname: Uzianbaeva, Yulia V – sequence: 18 givenname: Jost B surname: Jonas fullname: Jonas, Jost B |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32142129$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtP3DAUhS1ExfsPsKjcXTczvX7FzqbVCAFFAhVVsLYcxwFTx07jhGr-PZkOjIAVq2vpfvcc65x9tB1TdAh9ITAnAOTbg2lNdMO_1P9JnYtzChTmIAq5hfaokHzGFIjtV-9ddJTzA8DEEVYWYgftMko4JbTcQ6fXvXs0wUXrcGrw1TJ13uIrY8eQOjPcL_GiTfEOL-oxDBn7iA3-PebsTcTXqRuDGXyKh-hTY0J2R8_zAN2end6c_Jxd_jq_OFlczowANcyUrBQDV1pC60YWVhFWU1WQWlrObFXVIG1BlDKUN5QKpywoITjwqqwpNIIdoO9r3W6sWldbF4feBN31vjX9Uifj9dtN9Pf6Lj1qCQXwEiaBr88Cffo7ujzo1mfrQpgiTWPWlEnOaFkyPqGfX3ttTF6ym4ByDdg-5dy7ZoMQ0Kuq9Luq9Koqvapquv3x7tb64X-U07d9-JDC8VphIjbGVBaUKc6eACHyqow |
| CitedBy_id | crossref_primary_10_1016_j_ophtha_2021_04_032 crossref_primary_10_1136_bmjopen_2020_039183 crossref_primary_10_1038_s41598_022_26075_4 crossref_primary_10_1038_s41598_021_88579_9 crossref_primary_10_1167_iovs_65_8_38 crossref_primary_10_1097_APO_0000000000000639 crossref_primary_10_1167_iovs_66_4_82 crossref_primary_10_3389_fopht_2025_1632047 crossref_primary_10_1038_s41598_020_77344_z crossref_primary_10_1167_iovs_65_3_29 crossref_primary_10_3390_jcm12041317 crossref_primary_10_1016_j_apjo_2024_100123 crossref_primary_10_1167_iovs_62_5_5 crossref_primary_10_1016_j_xops_2025_100885 crossref_primary_10_1016_j_ophtha_2023_07_014 crossref_primary_10_3390_ijms24010080 crossref_primary_10_1016_j_preteyeres_2025_101402 crossref_primary_10_1167_iovs_63_10_18 crossref_primary_10_1111_aos_15131 crossref_primary_10_1001_jamanetworkopen_2021_21138 crossref_primary_10_1038_s41598_022_12004_y crossref_primary_10_1038_s41433_025_03782_6 crossref_primary_10_1016_j_compmedimag_2024_102464 crossref_primary_10_1038_s41433_025_03615_6 crossref_primary_10_1038_s41433_022_02026_1 crossref_primary_10_1038_s41598_022_16925_6 crossref_primary_10_1097_IAE_0000000000004281 crossref_primary_10_1016_j_ophtha_2021_04_027 crossref_primary_10_1016_j_exer_2023_109414 crossref_primary_10_1016_j_heliyon_2024_e31348 crossref_primary_10_1136_bjophthalmol_2021_318869 crossref_primary_10_1111_aos_15088 crossref_primary_10_1186_s40662_020_00210_6 crossref_primary_10_1038_s41433_021_01846_x crossref_primary_10_1097_APO_0000000000000466 crossref_primary_10_1038_s41598_022_25460_3 crossref_primary_10_1136_bjo_2022_321404 crossref_primary_10_1016_j_preteyeres_2020_100923 crossref_primary_10_1016_j_ymthe_2021_02_025 crossref_primary_10_1111_aos_16726 crossref_primary_10_3389_fnagi_2022_912755 crossref_primary_10_1167_iovs_62_3_21 crossref_primary_10_1167_iovs_64_6_5 crossref_primary_10_1177_11206721231185816 crossref_primary_10_1038_s41598_022_22580_8 crossref_primary_10_4103_meajo_meajo_154_24 crossref_primary_10_1016_j_heliyon_2023_e22394 crossref_primary_10_1016_j_ophtha_2021_12_014 crossref_primary_10_1096_fj_202001095RR crossref_primary_10_1016_j_oret_2021_02_006 crossref_primary_10_1016_j_preteyeres_2020_100933 crossref_primary_10_1111_aos_14937 crossref_primary_10_1016_j_ophtha_2023_08_026 crossref_primary_10_1038_s41598_021_98039_z crossref_primary_10_1186_s12886_025_04220_7 crossref_primary_10_1001_jamaophthalmol_2024_3707 crossref_primary_10_3390_diagnostics12051210 crossref_primary_10_1136_bjophthalmol_2020_316648 crossref_primary_10_1038_s41598_023_44561_1 crossref_primary_10_1016_j_pdpdt_2025_104680 crossref_primary_10_1016_j_preteyeres_2022_101156 crossref_primary_10_1038_s41598_020_69439_4 crossref_primary_10_2147_DMSO_S340211 crossref_primary_10_1136_bmjopen_2021_058464 crossref_primary_10_1097_APO_0000000000000288 crossref_primary_10_3390_jcm10225462 crossref_primary_10_1016_j_heliyon_2023_e13257 crossref_primary_10_1016_j_ophtha_2024_07_003 |
| Cites_doi | 10.1016/j.ophtha.2006.06.050 10.1016/S0140-6736(12)60272-4 10.1371/journal.pone.0082763 10.1016/S0161-6420(01)01024-7 10.1016/j.preteyeres.2012.04.001 10.1111/aos.2017.95.issue-5 10.1136/bjophthalmol-2017-311258 10.1016/S0140-6736(16)30388-9 10.1186/s12889-019-7016-6 10.1167/iovs.11-8343 10.1038/sj.eye.6702573 10.1371/journal.pone.0211186 10.1016/j.ophtha.2003.05.011 10.1001/jama.2013.281053 10.1016/j.ophtha.2018.01.035 10.1016/j.ophtha.2006.01.035 10.1016/j.ophtha.2009.09.037 10.1371/journal.pone.0029692 10.1016/j.ophtha.2016.01.006 10.1016/j.ajo.2019.02.030 10.1016/j.ophtha.2017.12.005 10.1016/j.ophtha.2010.01.020 10.1016/j.ajo.2015.01.022 |
| ContentType | Journal Article |
| Copyright | Copyright 2020 Bikbov MM et al. . |
| Copyright_xml | – notice: Copyright 2020 Bikbov MM et al. . |
| DBID | ZGVWO AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1001/jamanetworkopen.2020.0567 |
| DatabaseName | JAMA Network (Open Access) CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: ZGVWO name: JAMA Network (Open Access) url: https://jamanetwork.com sourceTypes: Publisher – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Prevalence of Myopic Maculopathy Among Adults in a Russian Population |
| EISSN | 2574-3805 |
| ExternalDocumentID | PMC7060490 32142129 10_1001_jamanetworkopen_2020_0567 2762384 |
| Genre | Journal Article |
| GroupedDBID | ZGVWO 0R~ 53G 7X7 8FI 8FJ AAYXX ABUWG ADBBV ADPDF AFFHD AFKRA ALMA_UNASSIGNED_HOLDINGS AMJDE BCNDV BENPR CCPQU CITATION EBS EMOBN FYUFA GROUPED_DOAJ H13 HMCUK OK1 OVD OVEED PHGZM PHGZT PIMPY RAJ TEORI UKHRP W2D ALIPV M~E NPM 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-a508t-87b830e9c12df76c813d2861d7c43cbbd07c6188a24f225e8c0855404b9d20f53 |
| IEDL.DBID | ZGVWO |
| ISICitedReferencesCount | 75 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000519251800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2574-3805 |
| IngestDate | Tue Nov 04 01:57:47 EST 2025 Thu Sep 04 19:48:07 EDT 2025 Thu Jan 02 23:00:04 EST 2025 Sat Nov 29 06:31:24 EST 2025 Tue Nov 18 21:29:53 EST 2025 Fri Jul 05 02:02:27 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open access article distributed under the terms of the CC-BY License. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a508t-87b830e9c12df76c813d2861d7c43cbbd07c6188a24f225e8c0855404b9d20f53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://dx.doi.org/10.1001/jamanetworkopen.2020.0567 |
| PMID | 32142129 |
| PQID | 2374329934 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060490 proquest_miscellaneous_2374329934 pubmed_primary_32142129 crossref_primary_10_1001_jamanetworkopen_2020_0567 crossref_citationtrail_10_1001_jamanetworkopen_2020_0567 ama_primary_2762384 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-06 |
| PublicationDateYYYYMMDD | 2020-03-06 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAMA Network Open |
| PublicationTitleAlternate | JAMA Netw Open |
| PublicationYear | 2020 |
| Publisher | American Medical Association |
| Publisher_xml | – name: American Medical Association |
| References | Ohno-Matsui (zoi200040r4) 2015; 159 World Medical Association (zoi200040r13) 2013; 310 Sun (zoi200040r21) 2012; 53 zoi200040r12 Jonas (zoi200040r16) 2017; 95 Liu (zoi200040r17) 2010; 117 Xu (zoi200040r3) 2007; 114 Morgan (zoi200040r1) 2012; 379 Vongphanit (zoi200040r15) 2002; 109 Neelam (zoi200040r22) 2012; 31 Bourne (zoi200040r8) 2018; 102 Nangia (zoi200040r19) 2010; 117 Bikbov (zoi200040r9) 2019; 19 Wong (zoi200040r20) 2000; 41 Wu (zoi200040r6) 2013; 8 Fang (zoi200040r23) 2018; 125 Hsu (zoi200040r5) 2004; 111 Holden (zoi200040r7) 2016; 123 Vurgese (zoi200040r26) 2012; 7 Bikbov (zoi200040r10) 2019; 204 Bikbov (zoi200040r11) 2019; 14 Yan (zoi200040r24) 2018; 125 Lai (zoi200040r18) 2008; 22 Stevens (zoi200040r14) 2016; 388 Heine (zoi200040r25) 1899; 38 Xu (zoi200040r2) 2006; 113 |
| References_xml | – volume: 114 start-page: 216 issue: 2 year: 2007 ident: zoi200040r3 article-title: High myopia and glaucoma susceptibility the Beijing Eye Study. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.06.050 – volume: 379 start-page: 1739 issue: 9827 year: 2012 ident: zoi200040r1 article-title: Myopia. publication-title: Lancet doi: 10.1016/S0140-6736(12)60272-4 – volume: 8 issue: 12 year: 2013 ident: zoi200040r6 article-title: Refractive error, visual acuity and causes of vision loss in children in Shandong, China: the Shandong Children Eye Study. publication-title: PLoS One doi: 10.1371/journal.pone.0082763 – volume: 109 start-page: 704 issue: 4 year: 2002 ident: zoi200040r15 article-title: Prevalence and progression of myopic retinopathy in an older population. publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)01024-7 – volume: 31 start-page: 495 issue: 5 year: 2012 ident: zoi200040r22 article-title: Choroidal neovascularization in pathological myopia. publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2012.04.001 – volume: 95 start-page: e399 issue: 5 year: 2017 ident: zoi200040r16 article-title: Prevalence of myopic retinopathy in rural Central India. publication-title: Acta Ophthalmol doi: 10.1111/aos.2017.95.issue-5 – volume: 102 start-page: 575 issue: 5 year: 2018 ident: zoi200040r8 article-title: Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2017-311258 – volume: 388 start-page: e19 issue: 10062 year: 2016 ident: zoi200040r14 article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. publication-title: Lancet doi: 10.1016/S0140-6736(16)30388-9 – volume: 19 start-page: 762 issue: 1 year: 2019 ident: zoi200040r9 article-title: Prevalence and associated factors of anemia in a Russian population: the Ural Eye and Medical Study. publication-title: BMC Public Health doi: 10.1186/s12889-019-7016-6 – volume: 53 start-page: 7504 issue: 12 year: 2012 ident: zoi200040r21 article-title: High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai. publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8343 – volume: 22 start-page: 209 issue: 2 year: 2008 ident: zoi200040r18 article-title: Peripheral and posterior pole retinal lesions in association with high myopia: a cross-sectional community-based study in Hong Kong. publication-title: Eye (Lond) doi: 10.1038/sj.eye.6702573 – volume: 14 issue: 2 year: 2019 ident: zoi200040r11 article-title: Axial length and its associations in a Russian population: the Ural Eye and Medical Study. publication-title: PLoS One doi: 10.1371/journal.pone.0211186 – volume: 111 start-page: 62 issue: 1 year: 2004 ident: zoi200040r5 article-title: Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2003.05.011 – volume: 310 start-page: 2191 issue: 20 year: 2013 ident: zoi200040r13 article-title: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. publication-title: JAMA doi: 10.1001/jama.2013.281053 – volume: 125 start-page: 1253 issue: 8 year: 2018 ident: zoi200040r24 article-title: Ten-year progression of myopic maculopathy: the Beijing Eye Study 2001-2011. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2018.01.035 – volume: 38 start-page: 277 year: 1899 ident: zoi200040r25 article-title: Beiträge zur Anatomie des myopischen Auges. publication-title: Arch Augenheilk – ident: zoi200040r12 – volume: 113 start-page: 1134.e1 issue: 7 year: 2006 ident: zoi200040r2 article-title: Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.01.035 – volume: 117 start-page: 693 issue: 4 year: 2010 ident: zoi200040r19 article-title: Refractive error in central India: the Central India Eye and Medical Study. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2009.09.037 – volume: 7 issue: 1 year: 2012 ident: zoi200040r26 article-title: Scleral thickness in human eyes. publication-title: PLoS One doi: 10.1371/journal.pone.0029692 – volume: 123 start-page: 1036 issue: 5 year: 2016 ident: zoi200040r7 article-title: Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.01.006 – volume: 204 start-page: 130 issue: 8 year: 2019 ident: zoi200040r10 article-title: Intraocular pressure and its associations in a Russian population: the Ural Eye and Medical Study. publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2019.02.030 – volume: 125 start-page: 863 issue: 6 year: 2018 ident: zoi200040r23 article-title: Progression of myopic maculopathy during 18-year follow-up. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.12.005 – volume: 41 start-page: 2486 issue: 9 year: 2000 ident: zoi200040r20 article-title: Prevalence and risk factors for refractive errors in adult Chinese in Singapore. publication-title: Invest Ophthalmol Vis Sci – volume: 117 start-page: 1763 issue: 9 year: 2010 ident: zoi200040r17 article-title: Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2010.01.020 – volume: 159 start-page: 877 issue: 5 year: 2015 ident: zoi200040r4 article-title: International photographic classification and grading system for myopic maculopathy. publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2015.01.022 |
| SSID | ssj0002013965 |
| Score | 2.4103954 |
| Snippet | IMPORTANCE: Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of... Although myopic maculopathy has become a major cause of vision impairment worldwide, few data from Russia and Central Asia on the prevalence of myopic... This case-control study examines the prevalence of myopic maculopathy among individuals aged 40 years or older in rural and urban areas in Russia. |
| SourceID | pubmedcentral proquest pubmed crossref ama |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e200567 |
| SubjectTerms | Online Only Ophthalmology Original Investigation |
| Title | Prevalence of Myopic Maculopathy Among Adults in a Russian Population |
| URI | http://dx.doi.org/10.1001/jamanetworkopen.2020.0567 https://www.ncbi.nlm.nih.gov/pubmed/32142129 https://www.proquest.com/docview/2374329934 https://pubmed.ncbi.nlm.nih.gov/PMC7060490 |
| Volume | 3 |
| WOSCitedRecordID | wos000519251800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2574-3805 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002013965 issn: 2574-3805 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2574-3805 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002013965 issn: 2574-3805 databaseCode: 7X7 dateStart: 20180101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2574-3805 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002013965 issn: 2574-3805 databaseCode: BENPR dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2574-3805 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002013965 issn: 2574-3805 databaseCode: PIMPY dateStart: 20180101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED5BO028APsBdEDlSnsNsh2ndh7L1AISLRHaum4vUezEohJKEG2R-O85J22h6yQQL5Gi-Cz7zs6d7fP3AXy3wvrCBNTj0rQ9YZTwVMKYpxNmBdOZEuVmzvBSDgZqNAqj53vcayf4FT5QXqVEO0IpXNJxeoJuW25CncsgCGpQ_3s2_H31EVqvyrzEU134oLXA8t_8yBcOp7fzrqbuwvY8viSdakB8go0s_wJdB9SUlNeLSGFJ_7G4GxvST8zstnCUxI-k4ziHSMeBcUzIOCcJuZ5N3P1KEi0Zvr7Cr173549zb86f4CUYdk3xR6eVT7PQMJ5a2TaK-SlXbZZKI3yjdUrRPkyphAuL0zpTpkxao0KHKac28Peglhd5dgAkoZpaxlLNtBQiVaExTGO9OJupReEGfMa-x3cVQkbM8RfrK9EAtdBzbOaQ44754jauwJJx6bGqsdhpLHYaawBfii5qfYNQa2HMGGeJO_rAgsVsEnMfIyX0vD62ab8y7rJaR9WEDjxsgFwx-7KAQ-Be_ZKPb0ok7hJ6KKTf_tv7Q9hyLSsT1tpHUJvez7Jj-GAepuPJfRM25UiWT9WE-ml3EF03yw0BfIsu-tGf5nxYPwGwN_jT |
| linkProvider | American Medical Association |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Myopic+Maculopathy+Among+Adults+in+a+Russian+Population&rft.jtitle=JAMA+network+open&rft.au=Bikbov%2C+Mukharram+M&rft.au=Gilmanshin%2C+Timur+R&rft.au=Kazakbaeva%2C+Gyulli+M&rft.au=Zainullin%2C+Rinat+M&rft.date=2020-03-06&rft.eissn=2574-3805&rft.volume=3&rft.issue=3&rft.spage=e200567&rft_id=info:doi/10.1001%2Fjamanetworkopen.2020.0567&rft_id=info%3Apmid%2F32142129&rft.externalDocID=32142129 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2574-3805&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2574-3805&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2574-3805&client=summon |